| Income Statement |
| Total Revenue | 28.54M |
|
| Revenues (USD) | 28.54M |
| Cost of Revenue | 22.80M |
| Gross Profit | 5.74M |
| Operating Expenses | 12.43M |
| Research and Development Expense | 3.80M |
| Selling, General and Administrative Expense | 8.63M |
| Operating Income | -6.69M |
| Net Income | -5.05M |
| Net Income Common Stock | -5.05M |
| Net Income Common Stock (USD) | -5.05M |
| Consolidated Income | -5.05M |
| Earnings per Basic Share | -0.04 |
| Earnings per Basic Share (USD) | -0.04 |
| Earnings per Diluted Share | -0.04 |
| Earning Before Interest & Taxes (EBIT) | -5.05M |
| Earning Before Interest & Taxes (USD) | -5.05M |
| Weighted Average Shares | 136.95M |
| Weighted Average Shares Diluted | 136.95M |
| Balance Sheet |
| Cash and Equivalents | 62.35M |
| Cash and Equivalents (USD) | 62.35M |
| Trade and Non-Trade Receivables | 35.26M |
| Current Assets | 113.95M |
| Property, Plant & Equipment Net | 16.77M |
| Total Assets | 130.78M |
| Debt Current | 1.17M |
| Total Debt | 6.56M |
| Current Liabilities | 15.98M |
| Debt Non-Current | 5.39M |
| Total Liabilities | 21.37M |
| Accumulated Retained Earnings (Deficit) | -223.40M |
| Accumulated Other Comprehensive Income | 10.00K |
| Shareholders Equity | 109.41M |
| Shareholders Equity (USD) | 109.41M |
| Assets Non-Current | 16.83M |
| Total Debt (USD) | 6.56M |
| Deferred Revenue | 18.00K |
| Inventory | 8.25M |
| Liabilities Non-Current | 5.39M |
| Trade and Non-Trade Payables | 8.88M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 1.38M |
| Net Cash Flow from Financing | 8.58M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -29.32M |
| Capital Expenditure | -625.00K |
| Issuance (Purchase) of Equity Shares | 8.58M |
| Net Cash Flow from Investing | -625.00K |
| Net Cash Flow from Operations | -37.27M |
| Effect of Exchange Rate Changes on Cash | 6.00K |
| Share Based Compensation | 2.06M |